Advertisement
Australia markets close in 3 hours 53 minutes

  • ALL ORDS

    7,872.30
    +40.40 (+0.52%)
     

  • ASX 200

    7,612.50
    +42.60 (+0.56%)
     

  • AUD/USD

    0.6535
    +0.0008 (+0.12%)
     

  • OIL

    79.36
    +0.36 (+0.46%)
     

  • GOLD

    2,334.20
    +23.20 (+1.00%)
     

  • Bitcoin AUD

    87,704.47
    -3,621.65 (-3.97%)
     

  • CMC Crypto 200

    1,255.45
    -83.62 (-6.25%)
     

  • AUD/EUR

    0.6094
    +0.0010 (+0.17%)
     

  • AUD/NZD

    1.1021
    +0.0021 (+0.19%)
     

  • NZX 50

    11,864.12
    -3.46 (-0.03%)
     

  • NASDAQ

    17,318.55
    -122.14 (-0.70%)
     

  • FTSE

    8,121.24
    -22.89 (-0.28%)
     

  • Dow Jones

    37,903.29
    +87.37 (+0.23%)
     

  • DAX

    17,932.17
    -186.15 (-1.03%)
     

  • Hang Seng

    17,944.19
    +181.16 (+1.02%)
     

  • NIKKEI 225

    38,189.03
    -85.02 (-0.22%)
     

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

Business Wire
·1-min read

MAHWAH, N.J., April 17, 2024--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2024 financial results on Wednesday, May 1, 2024. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for international callers. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.

About KORU Medical Systems

KORU Medical develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System ("the FREEDOM System") currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240410437582/en/

Contacts

Investor:
Greg Chodaczek
347-620-7010
investor@korumedical.com